Matches in SemOpenAlex for { <https://semopenalex.org/work/W2062393613> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2062393613 abstract "The aim of this study was to perform an independent review of the efficacy data and to determine whether the efficacy difference observed in a phase III randomised clinical trial that compared doxorubicin plus paclitaxel (AT) versus fluorouracil/doxorubicin/cyclophosphamide (FAC) in first-line chemotherapy of metastatic breast cancer was maintained after a longer follow-up period.A blinded independent review of original radiological images and original case report forms (CRFs) was conducted by an expert radiologist and an expert medical oncologist, respectively. The analysis of the updated data included time to progression (TTP) and overall survival (OS).CRFs for all 267 patients randomised in the study were available for medical review. The results of the independent review were consistent with the original analysis. At a median follow-up of 69 months, the difference in median TTP and OS in favour of the AT arm remained significant (median TTP 8.1 vs. 6.2 months, (p = 0.036); OS 23.0 vs. 18.3 months, (p = 0.005), respectively).This blinded independent review and analysis of updated data confirmed the advantage for AT over FAC with regard to TTP and OS in patients with metastatic breast cancer." @default.
- W2062393613 created "2016-06-24" @default.
- W2062393613 creator A5004874011 @default.
- W2062393613 creator A5005491386 @default.
- W2062393613 creator A5007240889 @default.
- W2062393613 creator A5014491534 @default.
- W2062393613 creator A5020876884 @default.
- W2062393613 creator A5023726343 @default.
- W2062393613 creator A5039307013 @default.
- W2062393613 creator A5050421775 @default.
- W2062393613 creator A5052978985 @default.
- W2062393613 creator A5077323428 @default.
- W2062393613 creator A5086255800 @default.
- W2062393613 date "2009-01-01" @default.
- W2062393613 modified "2023-10-16" @default.
- W2062393613 title "Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial" @default.
- W2062393613 cites W2330814896 @default.
- W2062393613 doi "https://doi.org/10.1159/000226210" @default.
- W2062393613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19745590" @default.
- W2062393613 hasPublicationYear "2009" @default.
- W2062393613 type Work @default.
- W2062393613 sameAs 2062393613 @default.
- W2062393613 citedByCount "12" @default.
- W2062393613 countsByYear W20623936132013 @default.
- W2062393613 countsByYear W20623936132014 @default.
- W2062393613 countsByYear W20623936132015 @default.
- W2062393613 countsByYear W20623936132016 @default.
- W2062393613 countsByYear W20623936132017 @default.
- W2062393613 countsByYear W20623936132018 @default.
- W2062393613 crossrefType "journal-article" @default.
- W2062393613 hasAuthorship W2062393613A5004874011 @default.
- W2062393613 hasAuthorship W2062393613A5005491386 @default.
- W2062393613 hasAuthorship W2062393613A5007240889 @default.
- W2062393613 hasAuthorship W2062393613A5014491534 @default.
- W2062393613 hasAuthorship W2062393613A5020876884 @default.
- W2062393613 hasAuthorship W2062393613A5023726343 @default.
- W2062393613 hasAuthorship W2062393613A5039307013 @default.
- W2062393613 hasAuthorship W2062393613A5050421775 @default.
- W2062393613 hasAuthorship W2062393613A5052978985 @default.
- W2062393613 hasAuthorship W2062393613A5077323428 @default.
- W2062393613 hasAuthorship W2062393613A5086255800 @default.
- W2062393613 hasConcept C121608353 @default.
- W2062393613 hasConcept C126322002 @default.
- W2062393613 hasConcept C141071460 @default.
- W2062393613 hasConcept C143998085 @default.
- W2062393613 hasConcept C2775930923 @default.
- W2062393613 hasConcept C2776694085 @default.
- W2062393613 hasConcept C2776755627 @default.
- W2062393613 hasConcept C2777292972 @default.
- W2062393613 hasConcept C2780456651 @default.
- W2062393613 hasConcept C2781303535 @default.
- W2062393613 hasConcept C530470458 @default.
- W2062393613 hasConcept C535046627 @default.
- W2062393613 hasConcept C71924100 @default.
- W2062393613 hasConceptScore W2062393613C121608353 @default.
- W2062393613 hasConceptScore W2062393613C126322002 @default.
- W2062393613 hasConceptScore W2062393613C141071460 @default.
- W2062393613 hasConceptScore W2062393613C143998085 @default.
- W2062393613 hasConceptScore W2062393613C2775930923 @default.
- W2062393613 hasConceptScore W2062393613C2776694085 @default.
- W2062393613 hasConceptScore W2062393613C2776755627 @default.
- W2062393613 hasConceptScore W2062393613C2777292972 @default.
- W2062393613 hasConceptScore W2062393613C2780456651 @default.
- W2062393613 hasConceptScore W2062393613C2781303535 @default.
- W2062393613 hasConceptScore W2062393613C530470458 @default.
- W2062393613 hasConceptScore W2062393613C535046627 @default.
- W2062393613 hasConceptScore W2062393613C71924100 @default.
- W2062393613 hasLocation W20623936131 @default.
- W2062393613 hasLocation W20623936132 @default.
- W2062393613 hasOpenAccess W2062393613 @default.
- W2062393613 hasPrimaryLocation W20623936131 @default.
- W2062393613 hasRelatedWork W1923449517 @default.
- W2062393613 hasRelatedWork W2025689023 @default.
- W2062393613 hasRelatedWork W2097536143 @default.
- W2062393613 hasRelatedWork W2101887613 @default.
- W2062393613 hasRelatedWork W2107577958 @default.
- W2062393613 hasRelatedWork W2141921153 @default.
- W2062393613 hasRelatedWork W2156836759 @default.
- W2062393613 isParatext "false" @default.
- W2062393613 isRetracted "false" @default.
- W2062393613 magId "2062393613" @default.
- W2062393613 workType "article" @default.